Company News

Share this article:

GlaxoSmithKline will extend its strategic collaboration with Aspen, a pharmaceutical manufacturer, through the acquisition of a 16% shareholding in the company. In return, Aspen received the right to distribute GSK products in South Africa. Aspen is the largest generics manufacturer in the southern hemisphere, according to the company's website.

 

Sanofi-Aventis announced that it will acquire commercial rights to Oforta, a leukemia treatment manufactured by Antisoma, for $60 million, with further payments totaling $5 million. Antisoma is a biotech based in London and Boston.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Apple selfies spur diabetes donations

Jazz apples has launched a Crunch to Contribute campaign to raise money for one of two diabetes associations.

Baxter seeks Cambridge, Mass. HQ

Illinois may be tempted to offer tax incentives for the firm to stay put.

FDA wants Alexion to clean up

FDA inspectors have cited the manufacturer of the rare-disease drug Soliris (eculizumab) for poor manufacturing practices.